MPA (Methiopropamine) is a new psychoactive substance (NPS), a stimulant drug, sold on its own or within a wide range of branded products. Find out more in this factsheet. Factsheet – MPA (PDF) NOTE: MPA is now controlled under the Psychoactive Substances Act 2016
Tag Archive for Druglink
Druglink article 2014 – Wrong arm of the law by Jessica Magson
The evidence from abroad, especially Portugal, suggests that scaling back on criminalising drug users in the UK could be a smart move, says Jessica Magson Despite major advances in drug treatment support over the past 20 years, punitive approaches to tackling illicit drug use remain…
Druglink article 2014 – Smack is back… but not here by Max Daly
The recent death of Phillip Seymour Hoffman has shed light on what appears to be a new heroin epidemic in America. Heroin use is on the wane in Britain. The battle against a drug that blighted many impoverished areas in the 1980s and 1990s…
Druglink interview 2014 – John Collins by Harry Shapiro
John Collins coordinates the international drug policy project at LSE IDEAS. He is the editor of the latest report to call for an end to the drugs war, but the analysis from this expert group of economists points to a more realistic, incremental approach than sweeping…
Druglink article 2014 – The acid test by David Ader
Psychedelic drugs such as LSD, MDMA and ketamine show promise in the treatment of mental health problems. The crossover between illicit drugs and medicines is nothing new. Opiates like heroin and morphine can be our most effective medical painkillers, yet cause immense harm to individuals and society. Some drugs…
Druglink article 2014 – Money talks by Max Daly
How successful are attempts to incentivise service users towards better health? The use of incentives to reward people for taking positive action, in the field of public health, is a relatively new and untested development in the UK. One of the first trials took place in…
Druglink article 2014 – Higher education by Max Daly
The public perception of the drug dealer is either a seedy street corner ne’er do well or a bling-laden ‘kingpin’. But Max Daly sheds light on a different world of dealing. A university campus is a drug dealer’s dream. Thousands of young people…
Druglink article 2014 – Buy one, get one free by Sara McGrail
In this second part of her two-part feature on commissioning, Sara McGrail offers a personal view on the growing supermarket model of service provision and how changes in commissioning have impacted on service users in England. Buy one, get one free (PDF)
Druglink news item 2014 – Children at risk
Adfam, the national charity for families affected by drugs and alcohol, have published a new report that shines a light on one of the murkier corners of addiction treatment. Medications in drug treatment: tackling the risks to children addresses the dangers presented to children when they ingest…
Druglink article 1999 – Education, education, education: the development of a specialised learning centre for drug users by Shelley Alge and Rita Kemp
The Government has announced that learning is at the heart of its welfare reform programme and a key element in tackling social exclusion. So where do people with drug problems fit in and how can their needs be resourced within…